Citi Sees Kadmon's Trials As 'Risky,' Initiates With Neutral Rating
August 22, 2016 at 11:13 AM EDT
Citi has initiated coverage of Kadmon Holdings Inc (NYSE: KDMN) at Neutral, while its $12 price target represents a potential return of ...